The e-consent and eligibility screening will be done via a virtual visit (Microsoft Teams or Zoom). During the e-consent we will provide much more information about the study protocol and help you to decide if you’d like to participate.

If you do decide to participate, we will go through a list of initial eligibility criteria and review the main study protocol components with you. If you meet the initial study eligibility criteria, we will then initiate the formal screening process (online survey and clinical screening interview) to determine if you are fully eligible to participate in the study. If you have any questions, feel free to email us at BIDMC-CFSC@bidmc.harvard.edu